Beyond the Eyepiece: A New Alliance Aims to Digitize the Operating Room

SEOUL, South Korea – June 18, 2026 – For decades, the image of a microsurgeon has been one of intense focus, hunched over the dual eyepieces of a powerful optical microscope. This iconic posture, a symbol of precision and dedication, has also been the source of chronic pain and physical limitation. Today, that era is poised to end.

In a move signaling a fundamental shift in surgical practice, South Korean innovator MediThinQ has entered into an exclusive global distribution agreement with Synovis Micro Companies Alliance, Inc., a subsidiary of healthcare giant Baxter International. The partnership will bring MediThinQ’s SHIYA 3D surgical visualization platform to operating rooms worldwide, aiming to replace the traditional microscope with a fully digital, data-enabled environment. This isn't just an upgrade; it's a strategic play to redefine the very infrastructure of complex surgery.

Unchaining the Surgeon

At the heart of this transformation is a simple but profound change: freeing the surgeon from the fixed eyepiece. Traditional optical microscopes, while effective, tether surgeons to a single position, often for hours on end. This constrained posture can lead to significant musculoskeletal strain, while also isolating the high-magnification view to the primary surgeon, limiting collaboration and training opportunities.

MediThinQ’s SHIYA platform dismantles these constraints. It combines a high-resolution digital exoscope, capable of up to 20x magnification, with a proprietary wearable display called SCOPEYE. Surgeons wear the lightweight display, which projects the surgical field in immersive 3D directly into their line of sight. They can now operate with a natural, heads-up posture, looking directly at the patient.

The impact is immediate. The entire surgical team—from assistants to nurses to trainees—can see the exact same high-definition view on large OR monitors. This shared visibility fosters a new level of communication and teamwork. "Digital visualization is not simply an incremental improvement over conventional microscopes – it fundamentally changes how surgeons interact with the operative field," said Prof. Joon-pio Hong, Chief Medical Officer of MediThinQ and a world-renowned microsurgeon. "The ability to operate in a heads-up position while sharing the same visual field with the entire team has important implications for precision, training, and surgical ergonomics."

A Strategic Play for a Multi-Billion Dollar Market

This alliance is far more than a technology showcase; it is a calculated business maneuver by Baxter, a titan with a market capitalization exceeding $10 billion, to secure a leading position in the future of surgery. The surgical visualization market is a space of explosive growth, valued at over $3 billion in 2024 and projected by analysts to surge past $8 billion by 2032, expanding at a compound annual growth rate (CAGR) of over 13%.

For MediThinQ, a nimble innovator with an estimated $7.7 million in annual revenue and $20.7 million in total funding, the partnership is a force multiplier. It provides instantaneous access to the global commercial infrastructure of Synovis MCA, a company that has spent over three decades building trust and deep relationships within the highly specialized world of microsurgery. As Seung Joon IM, Founder and CEO of MediThinQ, stated, the agreement is "an important step in making digital surgical visualization more widely accessible."

For Synovis MCA and its parent, Baxter, SHIYA represents a breakthrough technology that aligns perfectly with a strategic focus on "Advanced Surgery." It allows them to leapfrog incremental updates from competitors like ZEISS and Olympus and offer a platform that addresses core needs in the OR. "We are honored to work with MediThinQ as their global partner," said Michael Campbell, President of Synovis MCA. "SHIYA is aligned to our mission of being 'the microsurgeon's most trusted resource' by delivering innovative solutions that are safer, efficient, and more effective."

From Better Vision to Surgical Intelligence

The true long-term value of the SHIYA platform lies beyond ergonomics and shared screens. By converting the visual field from analog light into digital data, it transforms the operating room from a closed environment into a source of invaluable information. Where an optical microscope's view is ephemeral, a digital exoscope's feed can be captured, stored, analyzed, and shared globally.

This capability is the cornerstone of what MediThinQ calls "3D Surgical Intelligence." The vision is to create a connected surgical ecosystem where vast amounts of procedural data fuel advancements in artificial intelligence, advanced analytics, and robotics. Peer-reviewed studies in journals like Plastic and Reconstructive Surgery have already validated the platform's viability as an alternative to conventional microscopes and pointed toward its potential in emerging fields like supermicrosurgery and telemicrosurgery.

This data-centric approach promises to revolutionize surgical training. Instead of learning by peering over a senior surgeon's shoulder, residents can watch complex procedures in immersive 3D, and their own performance can be recorded for detailed, data-driven feedback. The platform lays the groundwork for a future where AI algorithms, trained on thousands of successful procedures, could provide real-time guidance to surgeons, enhancing precision and democratizing elite surgical skills. It’s no wonder that Dr. Peter Neligan, a global leader in the field, has described SHIYA as "the future of reconstructive microsurgery."

Navigating the Path to a New Standard

Despite the compelling vision, the path to widespread adoption is not without obstacles. The high cost of new digital systems, the learning curve for surgical teams, and the challenge of integrating with existing hospital IT infrastructure are significant hurdles. The market is also competitive, with established players vying for dominance.

The MediThinQ-Synovis MCA partnership appears designed to tackle these challenges head-on. The global rollout will be phased, tailored to the regulatory and market realities of each country, mitigating risk and allowing for a focused deployment. Synovis MCA's role is not just as a distributor, but as a clinical partner, leveraging its trusted reputation to guide hospitals through the adoption process.

By combining cutting-edge technology with a robust, trusted commercialization engine, this alliance is making a powerful statement. It is a bet that the future of surgery is not just about sharper instruments or better drugs, but about better information. The goal is to build a more efficient, effective, and intelligent operating room, ultimately creating a new standard of care for patients around the world.